Genmab A/S (GMAB)

Genmab Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	14,454	13,162	20,876	27,619	26,318	26,476
Market Cap Growth	-19.98%	-36.95%	-24.41%	4.94%	-0.60%	82.87%
Enterprise Value	11,712	10,895	16,911	24,292	23,518	23,661
Last Close Price	23.31	20.87	31.84	42.38	39.56	40.66
PE Ratio	1.08	12.09	32.35	35.26	58.19	33.86
PS Ratio	3.96	4.40	8.55	13.25	20.44	15.93
PB Ratio	2.73	2.58	4.45	7.05	7.75	8.43
P/TBV Ratio	4.52	4.35	4.47	7.08	7.84	8.58
P/FCF Ratio	13.25	12.50	20.07	53.47	87.08	26.30
P/OCF Ratio	12.74	12.20	19.08	49.14	77.23	25.04
EV/Sales Ratio	3.21	3.65	6.92	11.66	18.27	14.24
EV/EBITDA Ratio	8.82	10.62	20.63	25.79	48.86	22.00
EV/EBIT Ratio	9.19	11.09	21.43	26.98	52.07	22.81
EV/FCF Ratio	10.74	10.35	16.26	47.03	77.81	23.50
Debt / Equity Ratio	0.03	0.03	0.02	0.02	0.02	0.02
Debt / EBITDA Ratio	0.11	0.14	0.14	0.09	0.14	0.05
Debt / FCF Ratio	0.14	0.14	0.11	0.17	0.22	0.05
Asset Turnover	0.61	0.53	0.50	0.53	0.37	0.56
Inventory Turnover	21.91	16.56	-	-	-	-
Quick Ratio	6.20	5.24	13.32	15.48	14.50	15.00
Current Ratio	6.22	5.25	13.34	15.48	14.50	15.00
Return on Equity (ROE)	28.12%	22.97%	14.78%	22.04%	14.31%	28.69%
Return on Assets (ROA)	13.26%	10.91%	10.17%	14.31%	8.06%	21.75%
Return on Capital (ROIC)	15.86%	12.62%	11.04%	15.51%	8.78%	23.44%
Return on Capital Employed (ROCE)	21.80%	17.50%	16.20%	22.10%	12.80%	31.70%
Earnings Yield	9.48%	8.27%	3.09%	2.84%	1.72%	2.95%
FCF Yield	7.55%	8.00%	4.98%	1.87%	1.15%	3.80%
Buyback Yield / Dilution	3.37%	1.94%	0.14%	0.06%	-0.24%	-3.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q